Cite
Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection
MLA
Wu, Liviawati S., et al. “Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection.” Antimicrobial Agents and Chemotherapy, vol. 59, no. 4, Feb. 2015, pp. 2179–88. EBSCOhost, https://doi.org/10.1128/AAC.04618-14.
APA
Wu, L. S., Rower, J. E., Burton, J. R., Anderson, P. L., Hammond, K. P., Baouchi-Mokrane, F., Everson, G. T., Urban, T. J., D’Argenio, D. Z., & Kiser, J. J. (2015). Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy, 59(4), 2179–2188. https://doi.org/10.1128/AAC.04618-14
Chicago
Wu, Liviawati S., Joseph E. Rower, James R. Burton, Peter L. Anderson, Kyle P. Hammond, Fafa Baouchi-Mokrane, Gregory T. Everson, Thomas J. Urban, David Z. D’Argenio, and Jennifer J. Kiser. 2015. “Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection.” Antimicrobial Agents and Chemotherapy 59 (4): 2179–88. doi:10.1128/AAC.04618-14.